Full Text View
Tabular View
No Study Results Posted
Related Studies
Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors
This study has been completed.
Study NCT00091806.   Last updated on July 31, 2008.
Information provided by Amgen
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tumors
Oncology
Solid Tumors
Interventions listed in this trial
panitumumab (ABX-EGF)
Panitumumab
Sponsors listed in this trial
Amgen


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services